Merck’s First-Quarter Profit Forecast Falls Below Analyst Estimates

Merck & Co., the second-largest U.S. drugmaker, forecast first-quarter profit that falls below analysts’ estimates.

First quarter adjusted profit will be 95 cents to 98 cents a share, the Whitehouse Station, New Jersey-based company said today in a statement. That compares with analysts’ estimates of $1.01 a share. The company reaffirmed its 2012 full year adjusted profit of $3.75 to $3.85 a share.

To contact the editor responsible for this story: Will Daley at wdaley2@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.